In recent years, a non-invasive biopsy method called liquid biopsy has shown promise as a potential alternative to tissue biopsy, currently the gold standard in cancer detection and diagnosis. A tissue biopsy sample—traditionally collected through a surgical procedure that may require general anesthesia, accompanied by the risk of complications that may occur from any surgery, from pain through to infection and pneumonia—is typically tested for specific genetic variations, also referred to as mutations, which may offer information on a clear optimal treatment for that cancer.
Click here for original story, New ‘nanopores’ technique offers proof-of-concept of earlier, safer tumor detection
Source: Phys.org